drugset / Trial / NCT06819254
Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors
Phase 4
Recruiting
60 enrolled
Wake Forest University Health Sciences
The Ambrose Monell Foundation · collab
RandomizedCrossoverQuadruple-blindOther
Summary
The purpose of this study is to find out if taking a Fisetin supplement can decrease fatigue among older cancer survivors.
Timeline
- Start
- 2025-12-09
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fisetin | Small molecule | 20 mg/kg | — |
Indications
No indication recorded.